In patients with clinical ASCVD or HeFH, on top of maximally tolerated statins,
PRALUENT is the only PCSK9i with 2 powerful levels of efficacy to allow you to adjust the dose based on each patient’s LDL-C lowering needs1
PRESCRIBE PRALUENT:
LDL-C lowering power with flexible dosing options1